D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Opko Health
OPK
$993M
| $4.48M | 0.01% |
1,716,375
+1,692,210
| +7,003% | +$5.12M |
|
|
CHX
1577
DELISTED
ChampionX
CHX
| $4.47M | 0.01% |
108,791
-84,095
| -44% | -$3.11M |
|
1578
CALL
International Paper
IP
$22.8B
| $4.46M | 0.01% |
101,904
+22,810
| +29% | +$989K |
|
1579
CoreCivic
CXW
$2.95B
| $4.45M | 0.01% |
228,970
-265,094
| -54% | -$5.23M |
|
|
DPLO
1580
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.45M | 0.01% |
766,106
+719,819
| +1,555% | +$7.43M |
|
1581
Altria Group
MO
$113B
| $4.45M | 0.01% |
77,394
+55,003
| +246% | +$2.81M |
|
1582
EnerSys
ENS
$6.74B
| $4.44M | 0.01% |
68,182
-162,436
| -70% | -$12.3M |
|
1583
Manchester United
MANU
$4.04B
| $4.43M | 0.01% |
230,489
+21,001
| +10% | +$411K |
|
1584
CALL
Clorox
CLX
$11.7B
| $4.41M | 0.01% |
27,500
+20,000
| +267% | +$3.1M |
|
|
ODP
1585
DELISTED
ODP
ODP
| $4.4M | 0.01% |
121,268
+72,366
| +148% | +$2.32M |
|
1586
PUT
UnitedHealth
UNH
$383B
| $4.4M | 0.01% |
+17,800
| New | +$4.54M |
|
1587
Insight Enterprises
NSIT
$3.86B
| $4.4M | 0.01% |
79,869
-11,166
| -12% | -$563K |
|
|
GRUB
1588
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $4.4M | 0.01% |
31,650
-18,150
| -36% | -$2.81M |
|
|
WWE
1589
PUT
DELISTED
World Wrestling Entertainment
WWE
| $4.39M | 0.01% |
50,600
-23,500
| -32% | -$1.98M |
|
1590
Cato Corp
CATO
$66.5M
| $4.38M | 0.01% |
292,603
-43,757
| -13% | -$647K |
|
1591
PUT
Goodyear
GT
$2.04B
| $4.38M | 0.01% |
241,200
-426,800
| -64% | -$8.31M |
|
1592
PUT
XPO
XPO
$23.4B
| $4.37M | 0.01% |
+235,070
| New | +$4.51M |
|
1593
Brinker International
EAT
$9B
| $4.35M | 0.01% |
97,968
+27,400
| +39% | +$1.24M |
|
1594
Qorvo
QRVO
$8.01B
| $4.35M | 0.01% |
60,587
+17
| +0% | +$1.13K |
|
1595
PUT
Huntsman Corp
HUN
$2.12B
| $4.34M | 0.01% |
192,800
| – | – |
|
1596
MSCI
MSCI
$41.9B
| $4.33M | 0.01% |
21,761
-28,101
| -56% | -$4.89M |
|
1597
Phibro Animal Health
PAHC
$1.48B
| $4.32M | 0.01% |
130,924
+71,160
| +119% | +$2.21M |
|
|
HUD
1598
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $4.32M | 0.01% |
313,808
+264,626
| +538% | +$3.74M |
|
1599
PUT
US Bancorp
USB
$98B
| $4.31M | 0.01% |
+89,500
| New | +$4.49M |
|
1600
Tetra Tech
TTEK
$8.42B
| $4.31M | 0.01% |
361,385
+113,595
| +46% | +$1.27M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.